We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Botulinum toxin B reduces sialorrhea in parkinsonism.
- Authors
Racette, Brad A.; Good, Laura; Sagitto, Sandy; Perlmutter, Joel S.
- Abstract
We report on our open-label experience with botulinum toxin B for the treatment of severe sialorrhea associated with parkinsonism. Nine adult patients with parkinsonism and medically intractable sialorrhea were treated with botulinum toxin B (1,000 units into each parotid gland using superficial landmarks). After treatment, patients experienced a 61% mean subjective improvement and a 42% mean reduction of quantitative saliva production. There were no adverse effects seen in any subjects. Mean peak benefit from injections lasted 14 weeks. We conclude that denervation of salivary glands with botulinum toxin B produces excellent reduction of excessive salivation associated with parkinsonism. © 2003 Movement Disorder Society
- Publication
Movement Disorders, 2003, Vol 18, Issue 9, p1059
- ISSN
0885-3185
- Publication type
Article
- DOI
10.1002/mds.10484